182 related articles for article (PubMed ID: 36618714)
21. Fluoxetine hydrochloride loaded lipid polymer hybrid nanoparticles showed possible efficiency against SARS-CoV-2 infection.
Khater SE; El-Khouly A; Abdel-Bar HM; Al-Mahallawi AM; Ghorab DM
Int J Pharm; 2021 Sep; 607():121023. PubMed ID: 34416332
[TBL] [Abstract][Full Text] [Related]
22. The impact of the COVID-19 pandemic on stress and other psychological factors in pregnant women giving birth during the first wave of the pandemic.
Hübner T; Wolfgang T; Theis AC; Steber M; Wiedenmann L; Wöckel A; Diessner J; Hein G; Gründahl M; Kämmerer U; Kittel-Schneider S; Bartmann C
Reprod Health; 2022 Sep; 19(1):189. PubMed ID: 36064560
[TBL] [Abstract][Full Text] [Related]
23. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.
Moghimi N; Di Napoli M; Biller J; Siegler JE; Shekhar R; McCullough LD; Harkins MS; Hong E; Alaouieh DA; Mansueto G; Divani AA
Curr Neurol Neurosci Rep; 2021 Jun; 21(9):44. PubMed ID: 34181102
[TBL] [Abstract][Full Text] [Related]
24. Potential Role of the Antidepressants Fluoxetine and Fluvoxamine in the Treatment of COVID-19.
Mahdi M; Hermán L; Réthelyi JM; Bálint BL
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409171
[TBL] [Abstract][Full Text] [Related]
25. Risk of COVID-19 diagnosis and death in patients with mental illness: a cohort study.
Seon JY; Kim S; Hong M; Lim MK; Oh IH
Epidemiol Psychiatr Sci; 2021 Oct; 30():e68. PubMed ID: 34645538
[TBL] [Abstract][Full Text] [Related]
26. Editorial: The Pathogenesis of Long-Term Neuropsychiatric COVID-19 and the Role of Microglia, Mitochondria, and Persistent Neuroinflammation: A Hypothesis.
Stefano GB; Büttiker P; Weissenberger S; Martin A; Ptacek R; Kream RM
Med Sci Monit; 2021 May; 27():e933015. PubMed ID: 34016942
[TBL] [Abstract][Full Text] [Related]
27. Return-to-work, disabilities and occupational health in the age of COVID-19.
Godeau D; Petit A; Richard I; Roquelaure Y; Descatha A
Scand J Work Environ Health; 2021 Jul; 47(5):408-409. PubMed ID: 34003294
[TBL] [Abstract][Full Text] [Related]
28. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
29. Health Care Utilization in the 6 Months Following SARS-CoV-2 Infection.
Tartof SY; Malden DE; Liu IA; Sy LS; Lewin BJ; Williams JTB; Hambidge SJ; Alpern JD; Daley MF; Nelson JC; McClure D; Zerbo O; Henninger ML; Fuller C; Weintraub E; Saydah S; Qian L
JAMA Netw Open; 2022 Aug; 5(8):e2225657. PubMed ID: 35960522
[TBL] [Abstract][Full Text] [Related]
30. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
[TBL] [Abstract][Full Text] [Related]
31. SARS-Cov-2 Damage on the Nervous System and Mental Health.
Boulkrane MS; Ilina V; Melchakov R; Arisov M; Fedotova J; Gozzo L; Drago F; Lu W; Sarapultsev A; Tseilikman V; Baranenko D
Curr Neuropharmacol; 2022; 20(2):412-431. PubMed ID: 34191699
[TBL] [Abstract][Full Text] [Related]
32. Gastrointestinal symptoms in COVID-19: the long and the short of it.
Freedberg DE; Chang L
Curr Opin Gastroenterol; 2022 Nov; 38(6):555-561. PubMed ID: 36165028
[TBL] [Abstract][Full Text] [Related]
33. Long-Term Symptoms Among Adults Tested for SARS-CoV-2 - United States, January 2020-April 2021.
Wanga V; Chevinsky JR; Dimitrov LV; Gerdes ME; Whitfield GP; Bonacci RA; Nji MAM; Hernandez-Romieu AC; Rogers-Brown JS; McLeod T; Rushmore J; Lutfy C; Bushman D; Koumans E; Saydah S; Goodman AB; Coleman King SM; Jackson BR; Cope JR
MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(36):1235-1241. PubMed ID: 34499626
[TBL] [Abstract][Full Text] [Related]
34. Potential role of astrocyte angiotensin converting enzyme 2 in the neural transmission of COVID-19 and a neuroinflammatory state induced by smoking and vaping.
Zhang Y; Archie SR; Ghanwatkar Y; Sharma S; Nozohouri S; Burks E; Mdzinarishvili A; Liu Z; Abbruscato TJ
Fluids Barriers CNS; 2022 Jun; 19(1):46. PubMed ID: 35672716
[TBL] [Abstract][Full Text] [Related]
35. Ivermectin for preventing and treating COVID-19.
Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
[TBL] [Abstract][Full Text] [Related]
36. Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic.
Matta J; Wiernik E; Robineau O; Carrat F; Touvier M; Severi G; de Lamballerie X; Blanché H; Deleuze JF; Gouraud C; Hoertel N; Ranque B; Goldberg M; Zins M; Lemogne C;
JAMA Intern Med; 2022 Jan; 182(1):19-25. PubMed ID: 34747982
[TBL] [Abstract][Full Text] [Related]
37. Adverse events and tolerability of the combination of fluoxetine/lithium compared with fluoxetine.
Bauer M; Linden M; Schaaf B; Weber HJ
J Clin Psychopharmacol; 1996 Apr; 16(2):130-4. PubMed ID: 8690828
[TBL] [Abstract][Full Text] [Related]
38. Subacute administration of fluoxetine prevents short-term brain hypometabolism and reduces brain damage markers induced by the lithium-pilocarpine model of epilepsy in rats.
Shiha AA; de Cristóbal J; Delgado M; Fernández de la Rosa R; Bascuñana P; Pozo MA; García-García L
Brain Res Bull; 2015 Feb; 111():36-47. PubMed ID: 25541342
[TBL] [Abstract][Full Text] [Related]
39. Microdose lithium reduces cellular senescence in human astrocytes - a potential pharmacotherapy for COVID-19?
Viel T; Chinta S; Rane A; Chamoli M; Buck H; Andersen J
Aging (Albany NY); 2020 Jun; 12(11):10035-10040. PubMed ID: 32534451
[TBL] [Abstract][Full Text] [Related]
40. Letter to the Editor: THE IMPACT OF THE COVID-19 PANDEMIC ON SCHIZOPHRENIA PATIENTS.
Hoşgelen EI; Alptekin K
Turk Psikiyatri Derg; 2021; 32(3):219-221. PubMed ID: 34750798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
